Human Genome Epidemiology Literature Finder
Records 1 - 11 (of 11 Records) |
Query Trace: Neoplasms and SPARC[original query] |
---|
Secreted protein acidic and rich in cysteine (SPARC) gene polymorphism association with hepatocellular carcinoma in Italian patients. Journal of gastroenterology and hepatology 2009 Dec 24 (12): 1840-6. Segat Ludovica, Milanese Michele, Pirulli Doroti, Trevisiol Chiara, Lupo Francesco, Salizzoni Mauro, Amoroso Antonio, Crovella Serg |
An individual coding polymorphism and the haplotype of the SPARC gene predict gastric cancer recurrence. The pharmacogenomics journal 2013 Aug 13 (4): 342-8. Winder T, Wilson P M, Yang D, Zhang W, Ning Y, Power D G, Bohanes P, Gerger A, Tang L H, Shah M, Lenz H |
APC promoter is frequently methylated in pancreatic juice of patients with pancreatic carcinomas or periampullary tumors. Oncology letters 2016 Sep 12 (3): 2210-2216. Ginesta Mireia M, Diaz-Riascos Zamira Vanessa, Busquets Juli, Pelaez Núria, Serrano Teresa, Peinado Miquel Àngel, Jorba Rosa, García-Borobia Francisco Javier, Capella Gabriel, Fabregat Jo |
SPARC gene variants predict clinical outcome in locally advanced and metastatic pancreatic cancer patients. Medical oncology (Northwood, London, England) 2017 Aug 34 (8): 136. Arqueros Cristina, Salazar Juliana, Arranz M J, Sebio Ana, Mora Josefina, Sullivan Ivana, Tobeña María, Martín-Richard Marta, Barnadas Agustí, Baiget Montserrat, Páez Dav |
SPP1 rs4754 and its epistatic interactions with SPARC polymorphisms in gastric cancer susceptibility. Gene 2017 Sep . Chen Le-Zong, He Cai-Yun, Su Xuan, Peng Jun-Ling, Chen Dong-Liang, Ye Zulu, Yang Dong-Dong, Wang Zi-Xian, Wang Feng, Shao Jian-Yong, Xu Rui-H |
Association of SPARC gene polymorphisms rs3210714 and rs7719521 with VEGF expression and utility of Nottingham Prognostic Index scoring in breast cancer in a sample of Egyptian women. Molecular biology reports 2018 Sep . Bawazeer Sultan, Sabry Dina, Mahmoud Rania H, Elhanbuli Hala M, Yassen Noha N, Abdelhafez Marwa |
Polymorphisms in matricellular SPP1 and SPARC contribute to susceptibility to papillary thyroid cancer. Genomics 2020 9 112 (6): 4959-4967. Su Xuan, Xu Bo-Heng, Zhou Da-Lei, Ye Zu-Lu, He Hui-Chan, Yang Xin-Hua, Zhang Xiao, Liu Qing, Ma Jiang-Jun, Shao Qiong, Yang An-Kui, He Cai-Y |
The Somatic Mutation Landscape and RNA Prognostic Markers in Stomach Adenocarcinoma. OncoTargets and therapy 2020 8 13 7735-7746. Zhang Xiulei, Zheng Peiming, Li Zhen, Gao Shanjun, Liu Guangz |
Updated efficacy of adjuvant epirubicin plus cyclophosphamide followed by taxanes versus carboplatin plus taxanes in early triple-negative breast cancer in phase 2 trial: 8.1-year median follow-up. Breast cancer research and treatment 2021 10 191 (1): 97-105. Zheng Fangchao, Du Feng, Wang Wenmiao, Wang Yongsheng, Li Ming, Zhao Jiuda, Wang Xue, Yue Jian, Wang Jiayu, Yang Zixuan, Cai Ruigang, Ma Fei, Fan Ying, Li Qing, Zhang Pin, Xu Binghe, Yuan Pe |
Impact of SPARC expression on treatment response of pembrolizumab and brain metastasis in patients with metastatic non-small cell lung cancer. International immunopharmacology 2023 9 124 (Pt B): 110947. Sabin Goktas Aydin, Ahmet Bilici, Elif Calis, Yasin Kutlu, Jamshid Hamdard, Harun Muglu, Omer Fatih Olmez, Ebru Karci, Ozgur Acikg |
Secreted Protein Acidic and Rich in Cysteine (SPARC) Polymorphisms in Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer Patients. Biomedicines 2023 12 11 (12): . Cristina Arqueros, Juliana Salazar, Alberto Gallardo, Marta Andrés, Ariadna Tibau, Olga Lidia Bell, Alícia Artigas, Adriana Lasa, Teresa Ramón Y Cajal, Enrique Lerma, Agustí Barnad |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: